Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
6.17
-0.61 (-9.00%)
At close: Nov 20, 2024, 4:00 PM
6.30
+0.13 (2.11%)
After-hours: Nov 20, 2024, 7:47 PM EST

Perspective Therapeutics Market Cap

Perspective Therapeutics has a market cap or net worth of $417.02 million as of November 21, 2024. Its market cap has increased by 472.04% in one year.

Market Cap
417.02M
Enterprise Value
153.44M
1-Year Change
472.04%
Ranking
Category
Stock Price
$6.17

Market Cap Chart

Since November 10, 2005, Perspective Therapeutics's market cap has increased from $49.80M to $417.02M, an increase of 737.38%. That is a compound annual growth rate of 11.81%.

History

DateMarket Cap% Change
Nov 19, 2024458.20M306.21%
Dec 29, 2023112.80M221.37%
Dec 30, 202235.10M-36.18%
Dec 31, 202155.00M39.95%
Dec 31, 202039.30M-6.65%
Dec 31, 201942.10M108.42%
Dec 31, 201820.20M-8.18%
Dec 29, 201722.00M-31.03%
Dec 30, 201631.90M-38.18%
Dec 31, 201551.60M-35.58%
Dec 31, 201480.10M317.19%
Dec 31, 201319.20M-28.89%
Dec 31, 201227.00M41.36%
Dec 30, 201119.10M-28.20%
Dec 31, 201026.60M30.39%
Dec 31, 200920.40M343.48%
Dec 31, 20084.60M-90.09%
Dec 31, 200746.40M-40.28%
Dec 29, 200677.70M9.75%
Dec 30, 200570.80M42.17%
View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
ProKidney 482.70M
Y-mAbs Therapeutics 480.14M
MeiraGTx Holdings 475.95M
Cartesian Therapeutics 471.95M
GRAIL 470.41M
Alumis 470.08M
Taysha Gene Therapies 467.27M
Theravance Biopharma 466.66M
Market Cap Rankings